Browsing by Subject "Clinical Trials, Phase II as Topic"

Evaluation and recommendations on good clinical laboratory practice guidelines for phase I-III clinical trials.

Sarzotti-Kelsoe, Marcella; Cox, Josephine; Cleland, Naana; Denny, Thomas; Hural, John; Needham, Leila; Ozaki, Daniel; ... (12 authors) (PLoS Med, 2009-05-26)

Pitfalls of post-treatment PET after de-intensified chemoradiotherapy for HPV-associated oropharynx cancer: Secondary analysis of a phase 2 trial.

Wang, Kyle; Wong, Terence Z; Amdur, Robert J; Mendenhall, William M; Sheets, Nathan C; Green, Rebecca; Thorp, Brian D; ... (12 authors) (Oral oncology, 2018-03)

OBJECTIVES:We evaluated patterns of nodal response and positive predictive value (PPV) of 3 month post-treatment PET in patients with HPV-associated oropharyngeal cancer treated on a multi-institutional de-intensification ...

Prostatic alpha-linolenic acid (ALA) is positively associated with aggressive prostate cancer: a relationship which may depend on genetic variation in ALA metabolism.

Azrad, Maria; Zhang, Kui; Vollmer, Robin T; Madden, John; Polascik, Thomas J; Snyder, Denise C; Ruffin, Mack T; ... (11 authors) (PLoS One, 2012)

Previous observational studies have reported associations between prostate cancer and alpha-linolenic acid (ALA). However, few investigations have been able to study this relationship prospectively and in well-controlled ...